Vaccinex (VCNX) Competitors $0.63 +0.03 (+5.58%) As of 09/12/2025 02:08 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. CLDI, KTTA, AEZS, TTNP, BCTX, ADTX, PBM, PALI, TCRT, and SPRBShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Calidi Biotherapeutics (CLDI), Pasithea Therapeutics (KTTA), Aeterna Zentaris (AEZS), Titan Pharmaceuticals (TTNP), Briacell Therap (BCTX), Aditxt (ADTX), Psyence Biomedical (PBM), Palisade Bio (PALI), Alaunos Therapeutics (TCRT), and Spruce Biosciences (SPRB). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Its Competitors Calidi Biotherapeutics Pasithea Therapeutics Aeterna Zentaris Titan Pharmaceuticals Briacell Therap Aditxt Psyence Biomedical Palisade Bio Alaunos Therapeutics Spruce Biosciences Calidi Biotherapeutics (NYSE:CLDI) and Vaccinex (NASDAQ:VCNX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment. Which has higher valuation & earnings, CLDI or VCNX? Vaccinex has higher revenue and earnings than Calidi Biotherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalidi BiotherapeuticsN/AN/A-$29.22MN/AN/AVaccinex$388K4.25-$20.25M-$48.27-0.01 Do institutionals & insiders have more ownership in CLDI or VCNX? 12.5% of Calidi Biotherapeutics shares are held by institutional investors. Comparatively, 50.1% of Vaccinex shares are held by institutional investors. 6.7% of Calidi Biotherapeutics shares are held by insiders. Comparatively, 51.5% of Vaccinex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is CLDI or VCNX more profitable? Company Net Margins Return on Equity Return on Assets Calidi BiotherapeuticsN/A N/A -344.45% Vaccinex N/A N/A -383.58% Does the media favor CLDI or VCNX? In the previous week, Calidi Biotherapeutics and Calidi Biotherapeutics both had 1 articles in the media. Vaccinex's average media sentiment score of 0.98 beat Calidi Biotherapeutics' score of -1.00 indicating that Vaccinex is being referred to more favorably in the news media. Company Overall Sentiment Calidi Biotherapeutics Negative Vaccinex Positive Which has more volatility & risk, CLDI or VCNX? Calidi Biotherapeutics has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, Vaccinex has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. SummaryVaccinex beats Calidi Biotherapeutics on 6 of the 7 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65M$934.71M$5.87B$10.14BDividend YieldN/A4.84%5.68%4.59%P/E Ratio-0.011.1074.5225.93Price / Sales4.2526.70549.78198.13Price / CashN/A19.5637.5660.44Price / Book-0.246.6912.166.29Net Income-$20.25M-$4.50M$3.28B$270.77M7 Day Performance19.53%8.75%0.87%3.88%1 Month Performance2.00%9.50%4.96%4.88%1 Year Performance-88.71%22.47%60.74%26.01% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinex0.8435 of 5 stars$0.63+5.6%N/A-88.7%$1.65M$388K-0.0140Gap UpCLDICalidi Biotherapeutics0.3581 of 5 stars$1.65flatN/A-88.4%$5.65MN/A0.0038Short Interest ↑KTTAPasithea Therapeutics0.676 of 5 stars$0.76-1.4%N/A-80.5%$5.65MN/A-0.103Short Interest ↑AEZSAeterna ZentarisN/A$3.08+1.3%N/A-24.9%$5.52M$2.37M-0.2120TTNPTitan Pharmaceuticals0.1475 of 5 stars$4.13+1.1%N/A-24.2%$5.49MN/A-1.4010Positive NewsShort Interest ↓Gap DownBCTXBriacell Therap2.8978 of 5 stars$7.97-0.3%$320.00+3,915.1%-91.5%$5.42MN/A-0.108Short Interest ↓ADTXAditxtN/A$1.07+16.1%N/A-100.0%$5.33M$130K0.0060PBMPsyence Biomedical0.6605 of 5 stars$2.82-1.4%N/A-96.3%$5.27MN/A0.00N/APALIPalisade Bio3.1023 of 5 stars$0.56-1.9%$12.00+2,042.9%-84.0%$5.11M$250K-0.1410Short Interest ↓Gap DownTCRTAlaunos Therapeutics0.3464 of 5 stars$2.30+5.0%N/A-3.7%$5.08M$10K-0.9340News CoveragePositive NewsShort Interest ↑Gap UpSPRBSpruce Biosciences1.8636 of 5 stars$9.00flat$131.25+1,358.3%-63.9%$5.06M$4.91M-9.5720 Related Companies and Tools Related Companies CLDI Competitors KTTA Competitors AEZS Competitors TTNP Competitors BCTX Competitors ADTX Competitors PBM Competitors PALI Competitors TCRT Competitors SPRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts